nGeno
VC Firm•Pre-Seed / Seed • Poland
nGeno owns 81,5% in SmartPatch Project. Wearable device "smart patch" to monitor vital body signs (temperature, HR, blood oxygenation, skin pH, hydrogenation). You can stick smart patch to your skin and monitor yourself. It is IoT (BLE) device, medical silicon, is active - battery. Can work also in passive mode.
Investment Areas
Typical Investment
0-€100k
Funding Stage
Pre-Seed / Seed
Headquarters
Poland